HiFiBiO Therapeutics Announces Oral Presentation at 2023 American Association for Cancer Research (AACR) Annual Meeting Apr 7, 2023 By Ivy Chen
Jan 5, 2023 By Vincent Tse HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Life Science Success Podcast
May 9, 2022 By sarahjibrin Lynn Bodarky Joins HiFiBiO Therapeutics as SVP, Global Head of Business Development and Alliance Management
Aug 9, 2021 By sarahjibrin HiFiBiO Strengthens its Senior Leadership Team in Preparation for First-in-Human Studies of Two Lead Immunoncology Programs and a Sustainable Pipeline
Mar 8, 2021 By sarahjibrin HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by PharmaBoardRoom and Genialis Podcast
Oct 27, 2020 By sarahjibrin HiFiBiO Therapeutics CEO Liang Schweizer Named one of the World’s Top Female Founders
Sep 24, 2020 By sarahjibrin HiFiBiO Therapeutics CEO Liang Schweizer Receives 2020 Extraordinary Women Advancing Healthcare Award
May 15, 2020 By sarahjibrin HiFiBiO Therapeutics Unveils Several Novel Antibodies Showing Promise to Be Precision Immunotherapies for Cancer Patients
Jan 11, 2020 By sarahjibrin Biotechs Build on Single-cell Analytics for Drug R&D, as Human Cell Atlas is Mapped
